(Q43742929)

English

Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

atrial fibrillation

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

F Bellandi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

I Simonetti

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Leoncini

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Frascarelli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

T Giovannini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R P Dabizzi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

88

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

640-645

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

The natural history of lone atrial fibrillation. A population-based study over three decades

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Atrial Fibrillation — Risk Marker for Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Antiarrhythmic drug therapy in the treatment of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Classification of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Cross-sectional echocardiography. III. Analysis of mathematic models for quantifying volume of symmetric and asymmetric left ventricles.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Response of atrial fibrillation to therapy: role of etiology and left atrial diameter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901806-9

7 January 2021

Identifiers

10.1016/S0002-9149(01)01806-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11564387%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43742929&oldid=2125262616"